{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:49:40Z","timestamp":1791323380224,"version":"4.3.1"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Instituto Bioclon"},{"name":"Rare Disease Therapeutics, Inc"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicon"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.toxicon.2013.07.018","type":"journal-article","created":{"date-parts":[[2013,8,13]],"date-time":"2013-08-13T03:46:04Z","timestamp":1376365564000},"page":"101-108","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"special_numbering":"C","title":["Subacute coagulopathy in a randomized, comparative trial of Fab and F(ab\u2032)2 antivenoms"],"prefix":"10.1016","volume":"74","author":[{"given":"Leslie V.","family":"Boyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter B.","family":"Chase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice A.","family":"Degan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Figge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alma","family":"Buelna-Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Luchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Alag\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.toxicon.2013.07.018_bib1","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1001\/archinte.159.7.706","article-title":"Recurrent and persistent coagulopathy following pit viper envenomation","volume":"159","author":"Boyer","year":"199912","journal-title":"Arch. Intern. Med."},{"issue":"2","key":"10.1016\/j.toxicon.2013.07.018_bib2","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1067\/mem.2001.113134","article-title":"Recurrence phenomena following immunoglobulin therapy of snake envenomations. Part II: guidelines for clinical management with crotaline Fab Antivenom","volume":"37","author":"Boyer","year":"2001","journal-title":"Ann. Emerg. Med."},{"key":"10.1016\/j.toxicon.2013.07.018_bib3","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1056\/NEJMoa0808455","article-title":"Antivenom for critically III children with neurotoxicity from scorpion stings","volume":"360","author":"Boyer","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.toxicon.2013.07.018_bib4","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1080\/15563650802039965","article-title":"Serum levels and urine detection of Centruroides sculpturatus venom in significantly envenomated patients","volume":"47","author":"Chase","year":"2008","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.toxicon.2013.07.018_bib5","series-title":"9th Pan-American Congress of the International Society on Toxinology. Juriquilla, Quer\u00e9tero, M\u00e9xico","article-title":"Immunoassay for the detection and quantitation of Centruroides scorpion venom in human plasma samples","author":"Ch\u00e1vez-M\u00e9ndez","year":"2007"},{"key":"10.1016\/j.toxicon.2013.07.018_bib6","series-title":"9th Pan-American Congress of the International Society on Toxinology. Juriquilla, Quer\u00e9tero, M\u00e9xico","article-title":"Development and validation of two solid-phase enzyme immunoassays (ELISA) for quantitation of horse F(ab\u2032)2-based and sheep Fab-based antivenoms in human plasma samples","author":"Ch\u00e1vez-M\u00e9ndez","year":"2007"},{"issue":"7","key":"10.1016\/j.toxicon.2013.07.018_bib7","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.toxicon.2010.02.022","article-title":"Methodology of clinical studies dealing with the treatment of envenomation","volume":"55","author":"Chippaux","year":"2010","journal-title":"Toxicon"},{"issue":"16","key":"10.1016\/j.toxicon.2013.07.018_bib8","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1001\/archinte.161.16.2030","article-title":"A randomized multicenter trial of crotalinae polyvalent immune Fab (ovine) antivenom for the treatment for crotaline snakebite in the United States","volume":"161","author":"Dart","year":"2001","journal-title":"Arch. Intern. Med."},{"issue":"3","key":"10.1016\/j.toxicon.2013.07.018_bib9","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/BF03161198","article-title":"Fatality in a case of envenomation by Crotalus adamanteus initially successfully treated with polyvalent ovine antivenom followed by recurrence of defibrinogenation syndrome","volume":"4","author":"Kitchens","year":"2008","journal-title":"J. Med. Toxicol."},{"key":"10.1016\/j.toxicon.2013.07.018_bib10","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-227X-11-2","article-title":"Unified treatment algorithm for the management of crotaline snakebite in the United States: results of an evidence-informed consensus workshop","volume":"11","author":"Lavonas","year":"2011","journal-title":"BMC Emerg. Med."},{"key":"10.1016\/j.toxicon.2013.07.018_bib11","unstructured":"Protherics, Inc. CroFab\u00ae Crotalidae polyvalent immune Fab (ovine), License No. 1575. Product package insert, revision June 2008."},{"key":"10.1016\/j.toxicon.2013.07.018_bib12","first-page":"1","article-title":"Effect of antivenom on venom pharmacokinetics in experimentally envenomed rabbits: toward an optimization of antivenom therapy","volume":"281","author":"Rivi\u00e9re","year":"1997","journal-title":"JPET"},{"key":"10.1016\/j.toxicon.2013.07.018_bib13","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1067\/mem.2002.123698","article-title":"Initial postmarketing experience with Crotalidae polyvalent immune Fab for treatment of rattlesnake envenomation","volume":"39","author":"Ruha","year":"2002","journal-title":"Ann. Emerg. Med."},{"key":"10.1016\/j.toxicon.2013.07.018_bib14","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0041-0101(02)00330-6","article-title":"The efficacy of two antivenoms against the venom of North American snakes","volume":"41","author":"Sanchez","year":"2003","journal-title":"Toxicon"},{"issue":"2","key":"10.1016\/j.toxicon.2013.07.018_bib15","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1067\/mem.2001.113135","article-title":"Recurrence phenomena following immunoglobulin therapy of snake envenomations. Part 1: pharmacokinetics and pharmacodynamics of immunoglobulin antivenoms and related antibodies","volume":"37","author":"Seifert","year":"2001","journal-title":"Ann. Emerg. Med."},{"issue":"1","key":"10.1016\/j.toxicon.2013.07.018_bib16","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0196-0644(97)70110-0","article-title":"Relationship of venom effects to venom antigen and antivenom serum concentrations in a patient with Crotalus atrox envenomation treated with a Fab antivenom","volume":"30","author":"Seifert","year":"1997","journal-title":"Ann. Emerg. Med."},{"key":"10.1016\/j.toxicon.2013.07.018_bib17","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.toxicon.2005.08.010","article-title":"Pharmacokinetics of a F(ab')2 scorpion antivenom in healthy human volunteers","volume":"46","author":"V\u00e1zquez","year":"2005","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2013.07.018_bib18","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.intimp.2010.01.005","article-title":"Pharmacokinetics in rabbits and anti-sphingomyelinase D neutralizing power of Fab, F(ab')2, IgG and IgG(T) fragments from hyper immune equine plasma","volume":"10","author":"V\u00e1zquez","year":"2010","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.toxicon.2013.07.018_bib19","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.intimp.2010.08.018","article-title":"Pharmacokinetics of a F(ab')2 scorpion antivenom administered intramuscularly in healthy human volunteers","volume":"10","author":"V\u00e1zquez","year":"2010","journal-title":"Int. Immunopharmacol."}],"container-title":["Toxicon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010113002675?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010113002675?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,13]],"date-time":"2018-10-13T21:20:07Z","timestamp":1539465607000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041010113002675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":19,"alternative-id":["S0041010113002675"],"URL":"https:\/\/doi.org\/10.1016\/j.toxicon.2013.07.018","relation":{},"ISSN":["0041-0101"],"issn-type":[{"value":"0041-0101","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Subacute coagulopathy in a randomized, comparative trial of Fab and F(ab\u2032)2 antivenoms","name":"articletitle","label":"Article Title"},{"value":"Toxicon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxicon.2013.07.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}